Changes in haematological variables with one-year treatment with pioglitazone, metformin and gliclazide in 3713 type 2 diabetic patients

被引：0
|
作者：
Belcher, G
Edwards, G
Urquhart, R
Eckland, D
Tan, M
Herz, M
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A111 / A111
页数：1
相关论文
共 50 条
  • [31] Intensified multifactorial treatment of screen-detected type 2 diabetic patients: the ADDITION Netherlands randomised study, one-year results
    Janssen, P. G. H.
    Gorter, K. J.
    Stolk, R. P.
    Rutten, G. E. H.
    DIABETOLOGIA, 2007, 50 : S50 - S50
  • [32] Effect of one year of treatment with exenatide in a group of obese type 2 diabetic patients
    Buysschaert, M.
    Derdelinckx, L.
    Duvivier, E.
    Ippersiel, V.
    Leonet, J.
    Oriot, P.
    Paris, I.
    Preumont, V.
    Scarniere, D.
    Warnotte, C. V.
    DIABETES & METABOLISM, 2010, 36 : A79 - A79
  • [33] Blood Pressure Control and Inflammatory Markers in Type 2 Diabetic Patients Treated with Pioglitazone or Rosiglitazone and Metformin
    Giuseppe Derosa
    Elena Fogari
    Arrigo F G Cicero
    Angela D'angelo
    Leonardina Ciccarelli
    Mario N Piccinni
    Fabio Pricolo
    Sibilla A T Salvadeo
    Alessia Gravina
    Ilaria Ferrari
    Roberto Fogari
    Hypertension Research, 2007, 30 : 387 - 394
  • [34] Differential action of pioglitazone and metformin on hepatic fat, substrate metabolism and perfusion in type 2 diabetic patients
    Rijzewijk, L. J.
    van der Meer, R. W.
    Lubberink, M.
    Lamb, H. J.
    Romijn, J. A.
    de Roos, A.
    Twisk, J. W.
    Heine, R. J.
    Lammertsma, A. A.
    Smit, J. W. A.
    Diamant, M.
    DIABETOLOGIA, 2009, 52 : S336 - S336
  • [35] ONE-YEAR ACARBOSE TREATMENT RAISES FASTING SERUM ACETATE IN DIABETIC-PATIENTS
    WOLEVER, TMS
    RADMARD, R
    CHIASSON, JL
    HUNT, JA
    JOSSE, RG
    PALMASON, C
    RODGER, NW
    ROSS, SA
    RYAN, EA
    TAN, MH
    DIABETIC MEDICINE, 1995, 12 (02) : 164 - 172
  • [36] Determinants of recovery from depression in type 2 diabetic patients after a one-year follow-up
    Pibernik-Okanovic, M
    Peros, K
    Begic, D
    Szabo, S
    Metelko, Z
    DIABETOLOGIA, 2005, 48 : A323 - A323
  • [37] One-year efficacy and safety of IDegLira in patients with type 2 diabetes
    Gough, S. C. L.
    Buse, J. B.
    Woo, V. C.
    Rodbard, H. W.
    Linjawi, S.
    Poulsen, P.
    Korsholm, L.
    Bode, B. W.
    DIABETOLOGIA, 2014, 57 : S39 - S39
  • [38] Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results
    Ristic, S.
    Collober-Maugeais, C.
    Cressier, F.
    Tang, P.
    Pecher, E.
    DIABETES OBESITY & METABOLISM, 2007, 9 (04): : 506 - 511
  • [39] One-Year Efficacy and Safety of IDegLira in Patients with Type 2 Diabetes
    Gough, Stephen C. L.
    Buse, John B.
    Woo, Vincent C.
    Rodbard, Helena W.
    Linjawi, Sultan
    Poulsen, Pernille
    Korsholm, Lars
    Bode, Bruce W.
    DIABETES, 2014, 63 : A17 - A17
  • [40] One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment
    Bunck, M. C.
    Mari, A.
    Corner, A.
    Eliasson, B.
    Shaginian, R. M.
    Wu, Y.
    Yan, P.
    Heine, R. J.
    Smith, U.
    Taskinen, M. -R.
    Yki-Jarvinen, H.
    Diamant, M.
    DIABETOLOGIA, 2009, 52 : S7 - S7
12345